COPD Clinical Trial 20193031

[LCID Study Number: 20193031]

A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira Lung Denervation System in Subjects with Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-3)

The purpose of this study is to evaluate the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of chronic obstructive pulmonary disease (COPD).

Disease/Condition: COPD

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

View NCT ID 03639051 on ClinicalTrials.gov
Protocol #: 20193031
Principal Investigator(s): Carla R. Lamb
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Category A Device